Keyphrases
Basolateral Amygdala
100%
Place Preference
100%
Anxiolytic Activity
100%
Cannabinoid Receptor 1 (CB1R)
100%
Arachidonylcyclopropylamide
100%
Addiction
28%
Cannabis
28%
AM251
28%
Active Substances
14%
Anxiety-like Behavior
14%
Elevated Plus Maze Test
14%
Medical Treatment
14%
Behavioral Experiment
14%
Δ9-tetrahydrocannabinol (Δ9-THC)
14%
Selective Agonist
14%
Selective Antagonist
14%
Induced Behavior
14%
Conditioned Place Preference Test
14%
Chronic Use
14%
Cannabis Use
14%
Behavior Preference
14%
Cannabis Users
14%
Behavior Disorders
14%
Neuropsychiatric Adverse Events
14%
Neuroscience
Behavior (Neuroscience)
100%
Basolateral Amygdala
100%
Cannabinoid Receptor Type 1
100%
Arachidonylcyclopropylamide
100%
Conditioned Place Preference
100%
Cannabis
42%
AM251
28%
Behavior Disorder
14%
Elevated Plus Maze
14%
Agonist
14%
Cannabis Addiction
14%
Tetrahydrocannabinol
14%